期刊文献+

老年Ⅱ型糖尿病脂蛋白(a)的测定及临床意义 被引量:10

DETERMINATION OF LIPOPROTEIN(a) AND ITS CLINICAL SIGNIFICANCE IN ELDERLY TYPE 2 DIABETES MELLITUS
暂未订购
导出
摘要 目的 :了解脂蛋白 (a)和老年Ⅱ型糖尿病血管并发症的关系。方法 :对老年Ⅱ型糖尿病包括血管并发症和无血管并发症病人及老年对照组进行脂蛋白 (a)、血脂、载脂蛋白和空腹血糖测定。结果 :老年Ⅱ型糖尿病血管并发症组Lp(a)、TC、TG、Apob10 0 、LDL -ch显著高于老年对照组 ;HDL -ch和ApoA1显著低于对照组 ;老年Ⅱ型糖尿病无血管并发症组Lp(a) ,TG显著高于老年对照组 ,HDL -ch显著低于对照组 ;老年Ⅱ型糖尿病血管并发症组Lp(a)和FPG呈显著正相关 ,老年Ⅱ型糖尿病Lp(a)和TC、TG、HDL -ch、LDL -ch、ApO显著不相关。结论 :脂蛋白 (a)与老年Ⅱ型糖尿病血管并发症密切相关。 Objective:To investigate the relationship between the levels of serum lipoprotein (a) and vascular complication in elderly type 2 diabetes mellitus (DM).Methods:The levels of serum lipids,Apo,Lp(a) and FPG in elderly type 2 DM cases(including with and without vascular complication) and elderly control group were determined.Results:The levels of Lp(a),TC,TG,ApoB 100 ,LDL-ch in eldely type 2 DM with vascular complication were significantly lower than those in control group;the Lp(a),TG in elderly type 2 DM without vascular complication were significantly higher than those in control group,the HDL-ch were significantly lower than control group.Lp(a) was significantly related to FPG in elderly type 2 DM with vascular complication;Lp(a) was not significantly related to TC,TG,HDL-ch,LDL-ch,Apo in elderly type 2 DM.Conclusions:There might be some relationship between high Lp(2) and vascular complication in elderly type 2 DM.
出处 《中国现代医学杂志》 CAS CSCD 2002年第20期21-22,共2页 China Journal of Modern Medicine
关键词 Ⅱ型糖尿病 脂蛋白(a) 测定 老年人 临床意义 Lipoprotein(a) Elderly Diabetes Mellitus
  • 相关文献

参考文献4

二级参考文献7

共引文献5

同被引文献71

  • 1侯泽,崔玉鲜,沃兴德,刘德文.老年2型糖尿病患者血清脂蛋白(a)水平与载脂蛋白(a)基因多态性分析[J].中国动脉硬化杂志,2001,9(3):223-226. 被引量:12
  • 2刘永煌,王秀容,李贵芳,蒋晓梅,李再平,郭丛兰,李俐,徐丽芸.老年糖尿病患者脂肪餐后脂代谢变化的特征[J].中国临床康复,2004,8(36):8224-8225. 被引量:3
  • 3Buse JB, Ginsberg HN, Bakris GL, et al Primary prevention of cardiovascular diseases in people with diabetes mellitus:a scientific statement from the American Heart Association and the American Diabetes Association[J]. Diabetes Care, 2007,30:162-170.
  • 4Sacks DB, Bruns DE, Goldstein DE, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus[J]. Clin Chem, 2002,48(3):436-472.
  • 5Wijekoon EP, Brosnan ME, Brosnan JT. Homocysteine metabolism in diabetes[J]. Bioehem Soc Trans, 2007,35(Pt5):1175.2.
  • 6Weir MR. Microalbuminuria and cardiovascular disease[J]. Clin J Am Soc Nephrol, 2007,2(3):581.
  • 7Deekert T, Kofoed-Enevoldsen A, Jensen T, et al. Microalbuminuria, implications for micro-and macrovascular disease [J]. Diabetes Care, 1992,15(9):1181.
  • 8Potter K, Hankey G J, Green D J, et al. Homocysteine or renal impairment: which is the real cardiovascular risk factor?[J]. Arterioscler Thromb Vasc Biol, 2008,28(6):1158.
  • 9Crouse JR,Harapold GH,Kakl FR,et al.Evaluation of a scoring system for extracanial cartid atherosclerosis extent with B-mode ultrasound[J].Storke,1986,17:270-274.
  • 10Strosznajder J,Chalimoniuk M.Biphasic enhaneemenide synthase activity and CGMP level following brain gerbils[J].Acta Neurobiol Exp Warsz,1996,56:71.

引证文献10

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部